Optimizing GMP Manufacturing of Lipid Nanoparticles

Lonza is now offering next-generation encapsulation of nucleic acids with FDmiX. In this presentation you will find data demonstrating that the use of this new mixing device results in high manufacturability, stability and homogeneity of nucleic acid Lipid Nanoparticles.

You may also be interested in:

First Name Last Name Business Email Company Name Country

State

Join our community to receive tailored insights and resources. You can unsubscribe at any time.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

Webinar (on-demand)

Solving Bispecific Antibody Heavy-Light Chain Mispairing with bYlok® Technology

Lonza’s bYlok® bispecific pairing technology is an innovative solution that drives correct...

How Does bYlok® Technology Work and How Can It Improve Bispecific Production?

Bispecific antibodies offer numerous potential clinical benefits, and the number of bispecifics in...

Immunogenicity Discovery Services

Q&A: Why Use GS piggyBac® Transposase Technology for Expression of Your Biotherapeutics?

Presentation (slides)

Optimizing GMP Manufacturing of Lipid Nanoparticles

Lonza is now offering next-generation encapsulation of nucleic acids with FDmiX. In this...

Simplify the encapsulation process of nucleic acid payloads with FDmiX technology

Enable a reliable, swift scale-up to cGMP manufacturing for mRNA encapsulation with the high-end...

scientists working in lab

Q&A: How to Maximise Cell Line Productivity and Efficiency

In this interview, Dr. Tabitha Bullock, a principal group leader at Lonza, tells us about some...

Can Elimination of Preclinical Animal Testing Accelerate the Path to IND?

The US Food and Drug Administration (FDA) can now approve Investigational New Drug (IND)...

Moving Away from Animal Testing: What are the Drivers and Which Drug Candidates Might Benefit?

The US Food and Drug Administration (FDA) can now approve Investigational New Drug (IND)...

Fabs & Fc-Fusion whitepaper

A Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development Programs

New molecular formats are gaining momentum in today’s market. They are extremely diverse and can...

tech working on drum

Adaptive Bioprocessing: Utilising Inline Raman Spectroscopy for Automated Control

Substantial progress has been made over the last decade in developing Raman concentration models...

Peer-reviewed publication

Exploring Proteoforms of the IgG2 Monoclonal Antibody Panitumumab Using Microchip Capillary...

The IgG2 type monoclonal antibody panitumumab is an anti-epidermal growth factor receptor (EGFR)...

Article 1 Mammmalian

Peer-reviewed publication

Automated Raman Feedback Control of Multiple Supplemental Feeds to Enable an Intensified High...

Biologics manufacturing is increasingly moving toward intensified processes that require novel...